Skip to main content
Top
Published in: Indian Journal of Hematology and Blood Transfusion 3/2016

01-09-2016 | Original Article

Correlation of Notch1/Hes1 Genes Expression Levels in Egyptian Paediatric Patients with Newly Diagnosed and Persistent Primary Immune(Idiopathic) Thrombocytopenic Purpura

Authors: Rania Mohsen Gawdat, Amira Ahmed Hammam, Dina Ahmed Ezzat

Published in: Indian Journal of Hematology and Blood Transfusion | Issue 3/2016

Login to get access

Abstract

Notch signalling is involved in the development of several autoimmune diseases, one of such diseases is ITP. The aim of this study was to investigate and compare the expression levels of Notch1 receptor and its target Hes1 gene in Egyptian paediatric ITP patients. Real-time quantitative reverse transcriptase polymerase chain reaction was used to analyse the expression levels of Notch1 and Hes1 in 42 children with primary ITP (22 newly diagnosed and 20 persistent) cases. Twenty age and sex matched non-ITP controls were included. The expression levels of Notch1 were higher in newly diagnosed and persistent cases than controls with high statistical significant difference (P value < 0.001, P < 0.001) respectively, similarly as regards the expression levels of HES1 (P value < 0.001, P < 0.007) respectively. A significant positive correlation was found between Notch1 and Hes1 expression levels in newly diagnosed cases (r = 0.587, P value = 0.004). There was an association between levels of both genes in most of ITP patients but Hes1 was markedly elevated than Notch1 in few cases. High expression levels of Notch1/Hes1 indicated the important role of Notch signalling in both newly diagnosed and persistent ITP. High expression levels of Hes1 than Notch1 may shed light on its value as a therapeutic target for future research in ITP.
Literature
1.
go back to reference Artavanis-Tsakonas S, Rand MD, Lake RJ (1999) Notch signaling fate control and signal integration in development. Science 284(5415):770–776CrossRefPubMed Artavanis-Tsakonas S, Rand MD, Lake RJ (1999) Notch signaling fate control and signal integration in development. Science 284(5415):770–776CrossRefPubMed
2.
go back to reference De Strooper B, Annaert W, Cupers P, Safig P, Craessaerts K, Mumm JS, Schroeter EH, Schrijvers V, Wolfe MS, Ray WJ, Goate A, Kopan R (1999) A presenilin-1-dependent gamma-secretase-like protease mediates release of Notch intracellular domain. Nature 398:518–522CrossRefPubMed De Strooper B, Annaert W, Cupers P, Safig P, Craessaerts K, Mumm JS, Schroeter EH, Schrijvers V, Wolfe MS, Ray WJ, Goate A, Kopan R (1999) A presenilin-1-dependent gamma-secretase-like protease mediates release of Notch intracellular domain. Nature 398:518–522CrossRefPubMed
3.
go back to reference Osborne BA, Minter LM (2007) Notch signaling during peripheral T-cell activation and differentiation. Nat Rev Immunol 7:64–75CrossRefPubMed Osborne BA, Minter LM (2007) Notch signaling during peripheral T-cell activation and differentiation. Nat Rev Immunol 7:64–75CrossRefPubMed
4.
go back to reference Fischer A, Gressler M (2007) Delta Notch and then? Proteins interactions and proposed modes of repression by Hes and Hey b HLH factors. Nucleic Acid Res 35:4583–4956CrossRefPubMedPubMedCentral Fischer A, Gressler M (2007) Delta Notch and then? Proteins interactions and proposed modes of repression by Hes and Hey b HLH factors. Nucleic Acid Res 35:4583–4956CrossRefPubMedPubMedCentral
5.
go back to reference Hu X, Chung AY, Wu I, Foldi J, Chen J, Ji JD, Tateya T, Kang YJ, Han J, Gressler M, Kageyama R, Ivashkiv LB (2008) Integrated regulation of Toll- like receptor responses by Notch and interferon γ pathways. Immunity 29:663–665CrossRef Hu X, Chung AY, Wu I, Foldi J, Chen J, Ji JD, Tateya T, Kang YJ, Han J, Gressler M, Kageyama R, Ivashkiv LB (2008) Integrated regulation of Toll- like receptor responses by Notch and interferon γ pathways. Immunity 29:663–665CrossRef
6.
go back to reference Radtke F, MacDonald HR, Tacchini-Cottier F (2013) Regulation of innate and adaptive immunity by Notch. Immunology 13:427–437PubMed Radtke F, MacDonald HR, Tacchini-Cottier F (2013) Regulation of innate and adaptive immunity by Notch. Immunology 13:427–437PubMed
7.
go back to reference Radtke F, Fasnacht N, MacDonald HR (2010) Notch signaling in the immune system. Immunity 32:14–27CrossRefPubMed Radtke F, Fasnacht N, MacDonald HR (2010) Notch signaling in the immune system. Immunity 32:14–27CrossRefPubMed
8.
go back to reference Taigaki K, Honjo T (2007) Regulation of lymphocyte development by Notch signaling. Nat Immunol 8:451–456CrossRef Taigaki K, Honjo T (2007) Regulation of lymphocyte development by Notch signaling. Nat Immunol 8:451–456CrossRef
9.
go back to reference Eager TN, Tang Q, Woffe M, He Y, Pear WS, Bluestone JA (2004) Notch1 signaling regulates peripheral cell activation. Immunity 20:407–415CrossRef Eager TN, Tang Q, Woffe M, He Y, Pear WS, Bluestone JA (2004) Notch1 signaling regulates peripheral cell activation. Immunity 20:407–415CrossRef
10.
go back to reference Ostroukhova M, Qi Z, Orissis TB, Dixon-McCarthy B, Ray P, Ray A (2006) T-reg mediated immunosuppression involves activation of the Notch-Hes1 axis by membrane bound TGF- beta. J Clin Investig 116:996–1004CrossRefPubMedPubMedCentral Ostroukhova M, Qi Z, Orissis TB, Dixon-McCarthy B, Ray P, Ray A (2006) T-reg mediated immunosuppression involves activation of the Notch-Hes1 axis by membrane bound TGF- beta. J Clin Investig 116:996–1004CrossRefPubMedPubMedCentral
11.
go back to reference Asmen D, Antov A, Jankovic D, Sher A, Radtke F, Souabni A, Busslinger M, McCright B, Gridly T, Flavell RA (2007) Direct regulation of Gata3 expression determines T helper differentiation potential of Notch. Immunity 27:89–99CrossRef Asmen D, Antov A, Jankovic D, Sher A, Radtke F, Souabni A, Busslinger M, McCright B, Gridly T, Flavell RA (2007) Direct regulation of Gata3 expression determines T helper differentiation potential of Notch. Immunity 27:89–99CrossRef
12.
go back to reference Leong KG, Karasn A (2006) Recent insights into the role of Notch signaling in tumorgenesis. Blood 107:2223–2233CrossRefPubMed Leong KG, Karasn A (2006) Recent insights into the role of Notch signaling in tumorgenesis. Blood 107:2223–2233CrossRefPubMed
13.
go back to reference Talora C, Campese AF, Bellavia D, Felli MP, Vacca A, Gulino A, Screpanti I (2008) Notch signaling and diseases: an evolutionary journey from a simple beginning to complex outcomes. Biochim Biophys Acta 1782:489–497CrossRefPubMed Talora C, Campese AF, Bellavia D, Felli MP, Vacca A, Gulino A, Screpanti I (2008) Notch signaling and diseases: an evolutionary journey from a simple beginning to complex outcomes. Biochim Biophys Acta 1782:489–497CrossRefPubMed
14.
go back to reference Hannon MM, Lohan F, Erbilgin Y, Sayitoglu M, O’Hagan K, Mills K, Ozbek U, Keeshan K (2012) Elevated TRIB2 with Notch1 activation in pediatric/adult T-ALL. Br J Hematol 158:626–634CrossRef Hannon MM, Lohan F, Erbilgin Y, Sayitoglu M, O’Hagan K, Mills K, Ozbek U, Keeshan K (2012) Elevated TRIB2 with Notch1 activation in pediatric/adult T-ALL. Br J Hematol 158:626–634CrossRef
15.
go back to reference Palaga T, Minter LM (2013) Notch signaling and its emerging role in autoimmunity. Front Biol 8:279–294CrossRef Palaga T, Minter LM (2013) Notch signaling and its emerging role in autoimmunity. Front Biol 8:279–294CrossRef
16.
go back to reference Rodeghiero F, Stasi R, Gernsheimer T, Michel M, Provan D, Arnold DM, Bussel JB, Cines DB, Chong BH, Cooper N, Godeau B, Lechner K, Mazzucconi MG, McMillan R, Sanz MA, Imbach P, Blanchette V, Kuhne T, Ruggeri M, George JN (2009) Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura (ITP) of adults and children. Report from an international working group. Blood 113:2386–2393CrossRefPubMed Rodeghiero F, Stasi R, Gernsheimer T, Michel M, Provan D, Arnold DM, Bussel JB, Cines DB, Chong BH, Cooper N, Godeau B, Lechner K, Mazzucconi MG, McMillan R, Sanz MA, Imbach P, Blanchette V, Kuhne T, Ruggeri M, George JN (2009) Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura (ITP) of adults and children. Report from an international working group. Blood 113:2386–2393CrossRefPubMed
17.
go back to reference Kuhne T (2013) Update of the international co-operative ITP study (ICIS) on the pediatric and adult registry on chronic ITP (PARC ITP). Pediatr Blood Cancer 60:S15–S18CrossRefPubMed Kuhne T (2013) Update of the international co-operative ITP study (ICIS) on the pediatric and adult registry on chronic ITP (PARC ITP). Pediatr Blood Cancer 60:S15–S18CrossRefPubMed
18.
go back to reference World Medical Association(2008). Declaration of Helsinki. Ethical principles for medical research involving human subjects. The 59th WMA General Assembly, Seoul, South Korea World Medical Association(2008). Declaration of Helsinki. Ethical principles for medical research involving human subjects. The 59th WMA General Assembly, Seoul, South Korea
19.
go back to reference Bates I, Lewis SM (2011) Reference ranges and normal values. In: Bain BJ, Bates I, Laffan MA, Lewis SM (eds) Dacie and Lewis practical hematology, 11th edn. CURCHILL LIVINGSTONE, London, pp 16–17 Bates I, Lewis SM (2011) Reference ranges and normal values. In: Bain BJ, Bates I, Laffan MA, Lewis SM (eds) Dacie and Lewis practical hematology, 11th edn. CURCHILL LIVINGSTONE, London, pp 16–17
20.
go back to reference Bates I, Burthern J (2011) Bone marrow biopsy. In: Bain BJ, Bates I, Laffan MA, Lewis SM (eds) Dacie and Lewis practical hematology, 11th edn. CURCHILL LIVINGSTONE, London, p 130 Bates I, Burthern J (2011) Bone marrow biopsy. In: Bain BJ, Bates I, Laffan MA, Lewis SM (eds) Dacie and Lewis practical hematology, 11th edn. CURCHILL LIVINGSTONE, London, p 130
21.
go back to reference von dem Borne AE, Verheugt FW, Oosterhof F, von Riesz E, de la Riviere AB, Engelfreit CP (1978) A simple immunofluorescence test for the detection of platelet antibodies. Br J Hematol 39:195–207CrossRef von dem Borne AE, Verheugt FW, Oosterhof F, von Riesz E, de la Riviere AB, Engelfreit CP (1978) A simple immunofluorescence test for the detection of platelet antibodies. Br J Hematol 39:195–207CrossRef
22.
go back to reference Ma D, Dai J, Zhu X, Yan S (2010) Aberrant expression of Notch signaling molecules in patients with immune thrombocytopenic purpura. Ann Hematol 89:155–161CrossRefPubMed Ma D, Dai J, Zhu X, Yan S (2010) Aberrant expression of Notch signaling molecules in patients with immune thrombocytopenic purpura. Ann Hematol 89:155–161CrossRefPubMed
23.
go back to reference Johnsen J (2012) Pathogenesis in immune thrombocytopenia: new insights. Hematol Am Soc Hematol Educ Program 2012:306–312 Johnsen J (2012) Pathogenesis in immune thrombocytopenia: new insights. Hematol Am Soc Hematol Educ Program 2012:306–312
24.
go back to reference Tezgel AO, Gonzalez-Perez G, Tefer JC, Obsorne BA, Minter LM, Tew GN (2013) Novel protein transduction domain mimics as non-viral delivery for si RNA targeting Notch1 in primary human T cells. Mol Ther 21:201–209CrossRefPubMed Tezgel AO, Gonzalez-Perez G, Tefer JC, Obsorne BA, Minter LM, Tew GN (2013) Novel protein transduction domain mimics as non-viral delivery for si RNA targeting Notch1 in primary human T cells. Mol Ther 21:201–209CrossRefPubMed
25.
go back to reference Kageyama R, Ohtsuka T, Kobayashi T (2007) The Hes gene family: repressors and oscillators that orchestrate embryogenesis. Develoment 134:1243–1251 Kageyama R, Ohtsuka T, Kobayashi T (2007) The Hes gene family: repressors and oscillators that orchestrate embryogenesis. Develoment 134:1243–1251
26.
go back to reference Hoyne GF (2012) The role of Notch receptors and ligands in regulation of immune responses. Curr Trends Immunol 13:13–30 Hoyne GF (2012) The role of Notch receptors and ligands in regulation of immune responses. Curr Trends Immunol 13:13–30
27.
go back to reference Wall DS, Mears AJ, McNeill B, Mazerolle C, Thurig S, Wang Y, Kageyama R, Wallace VA (2009) Progenitor cell proliferation in the retina is dependent on Notch-independent Sonic hedgehog/Hes1 activity. J Cell Biol 184:101–112CrossRefPubMedPubMedCentral Wall DS, Mears AJ, McNeill B, Mazerolle C, Thurig S, Wang Y, Kageyama R, Wallace VA (2009) Progenitor cell proliferation in the retina is dependent on Notch-independent Sonic hedgehog/Hes1 activity. J Cell Biol 184:101–112CrossRefPubMedPubMedCentral
28.
go back to reference Ingram WJ, McCue KI, Tran TH, Hallahan AR, Wainwright BJ (2008) Sonic Hedgehog regulates Hes1 through a novel mechanism that is independent of canonical Notch pathway signaling. Oncogene 27:1489–1500CrossRefPubMed Ingram WJ, McCue KI, Tran TH, Hallahan AR, Wainwright BJ (2008) Sonic Hedgehog regulates Hes1 through a novel mechanism that is independent of canonical Notch pathway signaling. Oncogene 27:1489–1500CrossRefPubMed
29.
go back to reference Curry CL, Reed LL, Nickoloff BJ, Miele L, Foreman KE (2006) Notch-independent regulation of Hes-1 expression by c-Jun N-terminalkinase signaling in human endothelial cells. Lab Invest 86:842–852PubMed Curry CL, Reed LL, Nickoloff BJ, Miele L, Foreman KE (2006) Notch-independent regulation of Hes-1 expression by c-Jun N-terminalkinase signaling in human endothelial cells. Lab Invest 86:842–852PubMed
30.
go back to reference Sanalkumar R, Indulekha CL, Divya TS, Divya MS, Anto RJ, Vinod B, Vidyanand S, Jagatha B, Venugopal S, James J (2010) ATF2 maintains a subset of neural progenitors through CBF1/Notch independent Hes-1 expression and synergistically activates the expression of Hes-1 in Notch-dependent neural progenitors. J Neurochem 113:807–818CrossRefPubMed Sanalkumar R, Indulekha CL, Divya TS, Divya MS, Anto RJ, Vinod B, Vidyanand S, Jagatha B, Venugopal S, James J (2010) ATF2 maintains a subset of neural progenitors through CBF1/Notch independent Hes-1 expression and synergistically activates the expression of Hes-1 in Notch-dependent neural progenitors. J Neurochem 113:807–818CrossRefPubMed
31.
go back to reference Nakayama K, Satoh T, Igari A, Kageyama R, Nishida E (2008) FGF induces oscillations of Hes1 expression and Ras/ERK activation. Curr Biol 18:R332–R334CrossRefPubMed Nakayama K, Satoh T, Igari A, Kageyama R, Nishida E (2008) FGF induces oscillations of Hes1 expression and Ras/ERK activation. Curr Biol 18:R332–R334CrossRefPubMed
32.
33.
go back to reference Bennani-Biati IM, Aryee DN, Ban J, Machado I, Kauer M, Muhlbacher K, Amann G, Llombart-Bosch A, Kovar H (2011) Notch signalling is off and is uncoupled from HES1expression in Ewing Sarcoma. J Pathol 225:353–363CrossRef Bennani-Biati IM, Aryee DN, Ban J, Machado I, Kauer M, Muhlbacher K, Amann G, Llombart-Bosch A, Kovar H (2011) Notch signalling is off and is uncoupled from HES1expression in Ewing Sarcoma. J Pathol 225:353–363CrossRef
34.
go back to reference Yin G, Hou R, Li J, Zhang J (2012) Expression of Notch receptor and its target gene Hes-1 in bone marro CD4+ cells from patients with psoriasis. Dermatology 225:147–153CrossRefPubMed Yin G, Hou R, Li J, Zhang J (2012) Expression of Notch receptor and its target gene Hes-1 in bone marro CD4+ cells from patients with psoriasis. Dermatology 225:147–153CrossRefPubMed
35.
go back to reference Roderick J, Gonzalez-Perez G, Kuksin CA, Dongre A, Roberts ER, Srinivasan J, Andrzejewski C Jr, Fauq AH, Golde TE, Miele L, Minter LM (2013) Therapeutic targeting of NOTCH signaling ameliorates immune mediate bone marrow failure of aplastic anamia. J Exp Med 210:1311–1329CrossRefPubMedPubMedCentral Roderick J, Gonzalez-Perez G, Kuksin CA, Dongre A, Roberts ER, Srinivasan J, Andrzejewski C Jr, Fauq AH, Golde TE, Miele L, Minter LM (2013) Therapeutic targeting of NOTCH signaling ameliorates immune mediate bone marrow failure of aplastic anamia. J Exp Med 210:1311–1329CrossRefPubMedPubMedCentral
36.
go back to reference Jiao Z, Wang W, Guo M, Zhang T, Chen L, Wang Y, You H, Li J (2010) Expression analysis of Notch related molecules in peripheral blood T helper cells of patients with rheumatoid arthritis. Scand J Rheumatol 39:26–32CrossRefPubMed Jiao Z, Wang W, Guo M, Zhang T, Chen L, Wang Y, You H, Li J (2010) Expression analysis of Notch related molecules in peripheral blood T helper cells of patients with rheumatoid arthritis. Scand J Rheumatol 39:26–32CrossRefPubMed
37.
go back to reference Qi J, Yang Y, Hou S, Qiao Y, Wang Q, Yu H, Zhang Q, Cai T, KijlstraA Yang P (2014) Increased Notch pathway activation in Behcet’s disease. Reumatology 53:810–820CrossRef Qi J, Yang Y, Hou S, Qiao Y, Wang Q, Yu H, Zhang Q, Cai T, KijlstraA Yang P (2014) Increased Notch pathway activation in Behcet’s disease. Reumatology 53:810–820CrossRef
38.
go back to reference Sodasi P, Hirankarn N, Avihingsanon Y, Palaga T (2008) Defects in Notch1 upregulation upon activation of T cells from patients with systemic diseases. Lupus 17:645–653CrossRef Sodasi P, Hirankarn N, Avihingsanon Y, Palaga T (2008) Defects in Notch1 upregulation upon activation of T cells from patients with systemic diseases. Lupus 17:645–653CrossRef
39.
go back to reference Rauen T, Grammatikos AP, Hedrich CM, Floege J, Tenbrock K, Ohl K, Kyttaris VC, Tsokos GC (2012) c AMP-responsive element modulator α (CREMα) contributes to decreased Notch-1 expression in T cells from patients with active systemic lupus erythematosus (SLE). J Biol Chem 287:42525–42532CrossRefPubMedPubMedCentral Rauen T, Grammatikos AP, Hedrich CM, Floege J, Tenbrock K, Ohl K, Kyttaris VC, Tsokos GC (2012) c AMP-responsive element modulator α (CREMα) contributes to decreased Notch-1 expression in T cells from patients with active systemic lupus erythematosus (SLE). J Biol Chem 287:42525–42532CrossRefPubMedPubMedCentral
Metadata
Title
Correlation of Notch1/Hes1 Genes Expression Levels in Egyptian Paediatric Patients with Newly Diagnosed and Persistent Primary Immune(Idiopathic) Thrombocytopenic Purpura
Authors
Rania Mohsen Gawdat
Amira Ahmed Hammam
Dina Ahmed Ezzat
Publication date
01-09-2016
Publisher
Springer India
Published in
Indian Journal of Hematology and Blood Transfusion / Issue 3/2016
Print ISSN: 0971-4502
Electronic ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-015-0570-x

Other articles of this Issue 3/2016

Indian Journal of Hematology and Blood Transfusion 3/2016 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine